Results 111 to 120 of about 5,972 (163)
The use of ivabradine in a patient with inappropriate sinus tachycardia and cardiomyopathy due to limb girdle muscular dystrophy type 2I. [PDF]
BMJ Case Rep, 2020 Rajendram R +3 more
europepmc +1 more source
Stellate ganglion block and cardiac sympathetic denervation in patients with inappropriate sinus tachycardia. [PDF]
J Cardiovasc Electrophysiol, 2019 Cha YM +18 more
europepmc +1 more source
Inappropriate Sinus Tachycardia – Experience with Ivabradine [PDF]
Heart, Lung and Circulation, 2013 openaire +1 more source
Inappropriate Sinus Tachycardia: Current Challenges and Future Directions. [PDF]
J Innov Card Rhythm Manag, 2018 Yasin OZ +3 more
europepmc +1 more source
Inappropriate sinus tachycardia in pregnancy: a benign phenomena? [PDF]
BMJ Case Rep, 2017 Belham M, Patient C, Pickett J.
europepmc +1 more source
Radiofrequency catheter ablation for inappropriate sinus tachycardia in a patient with systemic lupus erythematosus: a case report. [PDF]
Eur Heart J Case Rep, 2019 Yoshizawa R +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Conventional management of inappropriate sinus tachycardia
Journal of Interventional Cardiac Electrophysiology, 2015Inappropriate sinus tachycardia is a challenging problem to manage. There are limited data on the best method to evaluate and treat the problem. Here, we consider a conventional approach to inappropriate sinus tachycardia.
Brian Olshansky, Olshansky Brian
exaly +3 more sources
Ivabradine in patients with inappropriate sinus tachycardia
Naunyn-Schmiedeberg's Archives of Pharmacology, 2010Inappropriate sinus tachycardia (IST) is characterized by paroxysmal tachycardia originating in the sinus nodal area. IST predominately affects young, female patients. Current antiarrhythmic drug treatment (ß-blockers, calcium antagonists), frequently complicated by side effects, is often not successful.
, , Paulus Kirchhof
exaly +3 more sources